Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022 17 4
N-[(2S)-1-[[(3S)-1-(benzenesulfonyl)-5-phenylpentan-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methylpiperazine-1-carboxamide Potential treatment - pre-clinical evidence Experimental Antiviral Mar/31/2021 1 0
rLVS ΔcapB/SCoV2 MN Potential treatment - pre-clinical evidence Experimental Vaccine Mar/30/2021 1 0
SinaCurcumin® Potential treatment - clinical evidence Experimental Antiviral Mar/28/2021 2 0
mAb 2-51 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021 2 0
mAB 4-8 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021 2 0
mAb 4A8 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021 2 0
mAB 5-24 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021 2 0
mAB 4-18 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021 2 0
mAB 1-68 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021 2 0
Excel (.xslx) CSV (.csv)